---
title: "Canopus released its 2024 annual performance, with a net profit attributable to the parent company of 97.4248 million yuan, a year-on-year increase of 0.21%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/235817008.md"
description: "Canopus released its 2024 annual report, with operating revenue of 435 million yuan, a year-on-year increase of 0.40%; net profit attributable to the parent company was 97.4248 million yuan, a year-on-year increase of 0.21%. The net profit excluding non-recurring gains and losses was 66.4591 million yuan, a year-on-year decrease of 2.49%. The basic earnings per share were 0.98 yuan, and it is proposed to distribute a cash dividend of 6 yuan for every 10 shares. The sales revenue of electric endoscopic stapler products increased by 131.92% year-on-year, becoming a new growth point for performance"
datetime: "2025-04-14T08:11:04.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/235817008.md)
  - [en](https://longbridge.com/en/news/235817008.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/235817008.md)
generator: "portal-rs"
---

# Canopus released its 2024 annual performance, with a net profit attributable to the parent company of 97.4248 million yuan, a year-on-year increase of 0.21%

According to the Zhitong Finance APP, Canopus (301290.SZ) released its annual report for 2024. During the reporting period, the company achieved an operating income of 435 million yuan, a year-on-year increase of 0.40%. The net profit attributable to shareholders of the listed company was 97.4248 million yuan, a year-on-year increase of 0.21%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 66.4591 million yuan, a year-on-year decrease of 2.49%. The basic earnings per share were 0.98 yuan. The company plans to distribute a cash dividend of 6 yuan (including tax) for every 10 shares to all shareholders.

During the reporting period, the company actively responded to market changes following the extensive implementation of the volume-based procurement policy and optimized its product structure. The sales revenue of the company's electric endoscope stapler products increased by 131.92% year-on-year, accounting for 25.79% of the operating income of stapler products in this period, becoming a new important growth point for the stapler business segment

### Related Stocks

- [301290.CN](https://longbridge.com/en/quote/301290.CN.md)

## Related News & Research

- [SF Holding Reports Solid First Half 2026 Results, Accelerating International Growth and Enhancing Shareholder Returns](https://longbridge.com/en/news/297341511.md)
- [Golf-PGA Tour overhauls post-season, moving to match play format in 2028](https://longbridge.com/en/news/296930417.md)
- [Gilde Healthcare’s SPI to acquire BENTEC Endoscopy](https://longbridge.com/en/news/297172511.md)
- [04:42 ETHollyland presenteert nieuwe oplossingen voor professionele liveproductie en contentcreatie op IBC 2026](https://longbridge.com/en/news/296881782.md)
- [17:18 ET/C O R R E C T I O N -- Bridge to Life, Ltd./](https://longbridge.com/en/news/297234294.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**